[1] Van der Linden S,Valkenburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis.A proposal for modification of the New York criteria[J].Arthritis Rheum,1984,27(4):361-368.
[2] Mitra D,Elvins DM,Speden DJ,et al.The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density[J].Rheumatology,2000,39(1):85-89.
[3] Jansen TL,Aarts MH,Zanen S,et al.Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis[J].Clin Exp Rheumatol,2003,21(5):599-604.
[4] 路平,阎小萍,陶庆文,等.强直性脊柱炎189名患者骨密度分析[J].中国临床保健杂志,2008,6(11):238-240.
[5] Holecki M,Zahorska-Markiewicz B,Chudek J,et al.Changes in bone mineral density and bone turnover markers in obese women after short-term weight loss therapy during a 5-year follow-up[J].Pol Arch Med Wewn,2010,120(7/8):248-254.
[6] Ichchou L,Allali F,Rostom S,et al.Relationship between spine osteoarthritis,bone mineral density and bone turn over markers in post menopausal women[J].BMC Women's Hearlth,2010,10(1):25.
[7] Arends S,Spoorenberg A,Bruyn GA,et al.The relation between bone mineral density,bone turnover markers,and vitamin D status in ankylosing spondylitis patients with active disease:a cross-sectional analysis[J].Osteoporos Int,2011,22(5):1431-1439.
[8] 厉小梅,李向培,汪国生,等.关节炎患者血清肿瘤坏死因子α的检测及意义[J].安徽医学,2002,2(6):12-13.
[9] Kang KY,Lee KY,Kwok SK,et al.The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis[J].Joint Bone Spine,2011,78(2):188-193.
[10] Grazio S,Grubisic F,Nemcic T,et al.The reliability and validity of a croatian version of the bath ankylosing spondylitis functional index(BASFI) and bath ankylosing spondylitis disease activity index(BASDAI) in patients with ankylosing spondylitis[J].Reumatizam,2009,56(2):63-76.
[11] 赵伟,黄烽.细胞核因子κB受体活化因子配基在强直性脊柱炎的表达及意义[J].解放军医学杂志,2004,29(6):482-485.
[12] Grisar J,Bernecker PM,Aringer M,et al.Ankylosing spondylitis,psoriatic arthritis,and reactive arthritis show increased bone resorption,but differ with regard to bone formation[J].J Rheumatol,2002,29(7):1430-1436.
[13] 贺晓燕,韩晴,陈曦,等.160例原发性甲状旁腺功能亢进症患者临床资料初步分析[J].诊断学理论与实践,2007,6(3):243-247.
[14] 周建平,李晓莉,董明,等.我国原发性甲状旁腺功能亢进症的误诊情况分析[J].中国现代医学杂志,2006,16(7):1040-1042.
[15] Harrison BJ,Triponez F.Intraoperative adjuncts in surgery for primary hyperparathyroidism[J].Langenbecks Arch Surg,2009,394(5):799-809.
[16] Wei JC,Lee HS,Chen WC,et al.Genetic polymorphisms of the matrix metalloproteinase-3(MMP-3) and tissue inhibitors of matrix metalloproteinases-1(TIMP-1) modulate the deve lopment of ankylosing spondylitis[J].Ann Rheum Dis,2009,68(11):1781-1786.